Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors

Primary or Metastatic Lung Tumors Clinical Trial

Official title: A Pilot Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors

Status Terminated

Clinical Trial Summary

This is an open-label, single-center, single-dose efficacy pilot study of AuroLase Therapy in the treatment of subjects with primary and/or metastatic tumors of the lung where there is airway obstruction. In this study patients will be given a systemic IV infusion of particles and a subsequent escalating dose of laser radiation delivered by optical fiber via bronchoscopy.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Lung Neoplasms
• Primary or Metastatic Lung Tumors

• NCT number: NCT01679470
• Study type: Interventional
• Source: Nanospectra Biosciences, Inc.
• Status: Terminated
• Phase: N/A
• Start date: October 2012
• Completion date: June 2014